About AarogyaAI
AarogyaAI is a company based in Bengaluru (India) founded in 2019 by Praapti Jayaswal. AarogyaAI has raised $753.92 thousand across 3 funding rounds from investors including GE Healthcare, Avaana Capital and Entrepreneur First. AarogyaAI operates in a competitive market with competitors including DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Ingenuity Systems, among others.
- Headquarter Bengaluru, India
- Founders Praapti Jayaswal
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aarogyaai Innovations Private Limited
- Date of Incorporation 31 May, 2019
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$22.14 K (USD)-27.22as on Mar 31, 2023
-
Net Profit
-$175.42 K (USD)-229.72as on Mar 31, 2023
-
EBITDA
-$186.04 K (USD)-150.02as on Mar 31, 2023
-
Total Equity Funding
$753.92 K (USD)
in 3 rounds
-
Latest Funding Round
$700 K (USD), Seed
Jan 07, 2022
-
Investors
GE Healthcare
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AarogyaAI
AarogyaAI has successfully raised a total of $753.92K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $700 thousand completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AarogyaAI
AarogyaAI has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include GE Healthcare, Avaana Capital and Entrepreneur First.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Avaana Capital is engaged in venture capital investments for deep tech startups.
|
Locked | Locked | Locked | |
|
Provider of a program turning individuals into funded technology company founders
|
Locked | Locked | Locked | |
|
Early stage investments in security technology are facilitated by First In.
|
Locked | Locked | Locked |
Investor details for AarogyaAI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AarogyaAI
Investment portfolio details for AarogyaAI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AarogyaAI
Detailed financials for AarogyaAI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aarogyaai Comparisons
Peer comparison for AarogyaAI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AarogyaAI
AarogyaAI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Ingenuity Systems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Genomic risk assessment and prevention platform is provided.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| Locked | Locked | Locked |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| Locked | Locked | Locked |
Developer of cloud-based software solutions for genomic analysis
|
Detailed competitors of AarogyaAI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aarogyaai
Complete news archive for AarogyaAI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AarogyaAI
AarogyaAI was founded in 2019.
AarogyaAI is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Praapti Jayaswal is the current CEO of AarogyaAI. They have also founded this company.
AarogyaAI is a funded company, having raised a total of $753.92K across 3 funding rounds to date.
Annual revenue of AarogyaAI is $22.14K as on Mar 31, 2023.
AarogyaAI was founded in 2019 in Bengaluru, India, within the healthcare technology sector. A proprietary platform is provided, leveraging AI and SaaS for tuberculosis diagnostics focused on drug resistance. Patient data is collected via DNA sequencing, and an analytics dashboard is offered to analyze bacterial phylogeny. Insights are generated for public health initiatives, including primary health center placements, pharmaceutical supply chain improvements, and drug development efforts.
AarogyaAI's top competitors include DNAnexus, Eagle Genomics and Depixus.
AarogyaAI has 5 investors. Key investors include GE Healthcare, Avaana Capital, Entrepreneur First, First In, and Redstart.
The valuation of AarogyaAI is $674.04K as of Sep 2019.